Pharma-Bio Serv (PBSV) Total Debt (2020 - 2024)

Pharma-Bio Serv (PBSV) has reported Total Debt for 3 consecutive years, with $1.7 million the latest figure, recorded in Q1 2024.

• For the quarter ending Q1 2024, Total Debt changed N/A year-over-year to $1.7 million; the trailing twelve-month figure through Jan 2024 stood at $1.7 million (changed N/A YoY), and the FY2020 full-year result was $1.9 million, changed N/A from the prior year.
• Total Debt eased to $1.7 million in Q1 2024 per PBSV's latest filing, from $1.9 million in the prior quarter.
• Across five years, Total Debt topped out at $1.9 million in Q2 2020 and bottomed at $1.7 million in Q1 2024.
• Historically, Total Debt has averaged $1.9 million across 3 years, with a median of $1.9 million in 2020.
• The widest YoY moves for Total Debt: up 0.0% in 2021, down 0.0% in 2021.
• Over 3 years, Total Debt stood at $1.9 million in 2020, then changed by 0.0% to $1.9 million in 2021, then decreased by 10.84% to $1.7 million in 2024.
• According to Business Quant data, Total Debt over the past three periods registered $1.7 million, $1.9 million, and $1.9 million for Q1 2024, Q2 2021, and Q1 2021 respectively.